Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ORGO
ORGO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ORGO News
Organogenesis Reports Record Q4 2025 Earnings Amid Market Uncertainty
Feb 27 2026
seekingalpha
Pomerantz LLP Investigates Securities Fraud Claims Against Organogenesis Holdings
Feb 03 2026
Globenewswire
Pomerantz LLP Investigates Securities Fraud Claims Against Organogenesis Holdings Inc.
Jan 22 2026
PRnewswire
Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%
Jan 08 2026
PRnewswire
Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%
Jan 06 2026
Globenewswire
Avista Healthcare Partners Promotes Three Key Executives in Investment Team
Jan 05 2026
Newsfilter
Organogenesis Faces Securities Fraud Investigation, Stock Drops 10.14%
Dec 30 2025
Globenewswire
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split, Shares Plunge 38.4%
Dec 26 2025
Benzinga
Organogenesis Submits BLA for ReNu, Expected Completion in 2026
Dec 24 2025
NASDAQ.COM
Organogenesis Initiates BLA Submission for ReNu, Targeting Knee Arthritis Treatment
Dec 23 2025
Globenewswire
Organogenesis Begins Rolling Submission for ReNu Allograft to Treat Knee Arthritis
Dec 23 2025
SeekingAlpha
B. Riley Financial Shares Surge Approximately 25%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 16 2025
Benzinga
Organogenesis Plans to Submit Rolling BLA for ReNu After FDA Discussion
Dec 16 2025
NASDAQ.COM
Post-Market Winners: Biotech and Med-Tech Stocks Rise on FDA Developments, Trial Clarity, and Merger Momentum
Dec 16 2025
NASDAQ.COM
Organogenesis Completes FDA Meeting, Plans BLA Submission by End of 2025
Dec 15 2025
Newsfilter
Organogenesis Shares Jump 54% Following Strong Q3 Revenue and Upgraded Forecast
Nov 07 2025
NASDAQ.COM
Show More News
